May 26, 2016 5:29 AM ET

Biotechnology

Company Overview of Adamas Pharmaceuticals, Inc.

Key Executives for Adamas Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Gregory T. Went Ph.D.27 RelationshipsChairman and Chief Executive Officer51
William J. Dawson 6 RelationshipsChief Financial Officer60
Natalie L. McClure Ph.D.No RelationshipsSenior Vice President of Product Development62
Rajiv Patni M.D.No RelationshipsChief Medical Officer46

Adamas Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Gregory T. Went Ph.D. 27 RelationshipsAdamas Pharmaceuticals, Inc.51
David L. Mahoney 42 RelationshipsAdamas Pharmaceuticals, Inc.61
Richard H. Booth CPA, CLU, ChFC 66 Relationships1347 Capital Corp.68
Martha J. Demski 37 RelationshipsAjinomoto Althea, Inc.62
William W. Ericson J.D. 156 RelationshipsWildcat Venture Partners56
View All Board Members

Adamas Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Martha J. Demski37 Relationships3 Executives
Compensation Committee CPA, CLU, ChFCRichard H. Booth66 Relationships2 Executives
Nominating Committee David L. Mahoney42 Relationships3 Executives
Corporate Governance Committee David L. Mahoney42 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$425.0K
425.0K
380.8K
Bonus$345.0K
345.0K
252.3K
Total Short Term Compensation
Not meaningful
Total Value of Options$770.0K
770.0K
33.7M
Compensation as of Fiscal Year 2015
Adamas Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Inivata Appoints Clive Morris as Chief Medical Officer
May 25, 2016 6:00 AM ET
Gilead Sciences, Inc. Announces Executive Changes
May 24, 2016 8:30 PM ET
Premier Biomedical, Inc. Appoints James Frincke as Chief Technical Officer
May 24, 2016 6:19 PM ET
Swedish Orphan Biovitrum AB Announces Board Appointments
May 24, 2016 5:00 PM ET
ARIAD Pharmaceuticals, Inc. Appoints Jennifer L. Herron as Executive Vice President and Chief Commercial Officer, Effective May 31, 2016
May 24, 2016 1:25 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Adamas Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.